MedTrace Logo

Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors

NCT05611307 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 31

Last updated 2025-08-11

No results posted yet for this study

Summary

Late subclinical cardiovascular disease in testicular cancer survivors exposed to cisplatin-based chemotherapy and bone marrow transplant

Conditions

  • Testicular Cancer
  • Survivorship
  • ASCVD
  • Coronary Artery Disease
  • Lipid Disorder
  • Hypogonadism, Male
  • Cisplatin Adverse Reaction
  • Bone Marrow Transplant Complications

Interventions

DIAGNOSTIC_TEST

Lipid profile

Advanced lipid profile

DIAGNOSTIC_TEST

Coronary artery assessment

Coronary artery assessment via CT scans

DIAGNOSTIC_TEST

Hormone levels for hypogonadism

Hormone levels for hypogonadism

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • Indiana University

    lead OTHER

Principal Investigators

  • Suparna C Clasen, MD MSCE · Indiana University

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-11
Primary Completion
2024-12-04
Completion
2024-12-04

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05611307 on ClinicalTrials.gov